AU2001283957A1 - Treatment of ocular disorders with somatostatin analogues - Google Patents
Treatment of ocular disorders with somatostatin analoguesInfo
- Publication number
- AU2001283957A1 AU2001283957A1 AU2001283957A AU8395701A AU2001283957A1 AU 2001283957 A1 AU2001283957 A1 AU 2001283957A1 AU 2001283957 A AU2001283957 A AU 2001283957A AU 8395701 A AU8395701 A AU 8395701A AU 2001283957 A1 AU2001283957 A1 AU 2001283957A1
- Authority
- AU
- Australia
- Prior art keywords
- treatment
- ocular disorders
- somatostatin analogues
- somatostatin
- analogues
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 208000022873 Ocular disease Diseases 0.000 title 1
- NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical class C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 title 1
- 229940075620 somatostatin analogue Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/31—Somatostatins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00116068 | 2000-07-27 | ||
| EP00116068 | 2000-07-27 | ||
| PCT/EP2001/008620 WO2002009739A1 (en) | 2000-07-27 | 2001-07-25 | Treatment of ocular disorders with somatostatin analogues |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001283957A1 true AU2001283957A1 (en) | 2002-02-13 |
Family
ID=8169349
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001283957A Abandoned AU2001283957A1 (en) | 2000-07-27 | 2001-07-25 | Treatment of ocular disorders with somatostatin analogues |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2001283957A1 (en) |
| WO (1) | WO2002009739A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7189856B2 (en) | 2001-12-28 | 2007-03-13 | Gideon Shapiro | Non-peptide somatostatin receptor ligands |
| ES2383303T3 (en) | 2005-11-10 | 2012-06-20 | Chemi S.P.A. | Formulations of somatostatin analogue growth hormone prolonged release inhibitors |
| ES2362604B1 (en) * | 2009-12-22 | 2012-06-28 | Bcn Peptides, S.A. | TYPICAL OPTIMAL FORMULATION OF PEPTIDES. |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000006185A2 (en) * | 1998-07-30 | 2000-02-10 | Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. | Methods of using lanreotide, a somatostatin analogue |
| CA2263042A1 (en) * | 1999-02-25 | 2000-08-25 | Robert W.A. Kuijpers | Treatment of edema |
-
2001
- 2001-07-25 AU AU2001283957A patent/AU2001283957A1/en not_active Abandoned
- 2001-07-25 WO PCT/EP2001/008620 patent/WO2002009739A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002009739A1 (en) | 2002-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002257936A1 (en) | Methods of well treatment | |
| GB0007193D0 (en) | Treatment of movrmrnt disorders | |
| AU2000260550A1 (en) | Treatment of skin damage using polyenylphosphatidylcholine | |
| AU2002303502A1 (en) | Improved leads for the treatment of patients with chf | |
| AU2002231206A1 (en) | Treatment of depression | |
| AU2001256855A1 (en) | Preparation for the prevention and treatment of ocular disorders | |
| AUPR074500A0 (en) | Treatment of t cell disorders | |
| AU2001260834A1 (en) | The treatment of herpes | |
| AU1356201A (en) | Treatment of hyperproliferative disorders | |
| AU2001251306A1 (en) | Treatment of sleep disorders with hypocretin-1 | |
| AU2002319286A1 (en) | Skin treatment | |
| AU2002362505A1 (en) | Compression sleeve for treatment of the extremities | |
| AU7106300A (en) | Treatment of skin disorders | |
| AU2001283957A1 (en) | Treatment of ocular disorders with somatostatin analogues | |
| AU2080201A (en) | Treatment of addiction disorders | |
| AU2002327440A1 (en) | Treatment of type i diabetes | |
| AU2002210763A1 (en) | Use of 1-ebio in the treatment of bipolar disorders | |
| AU1405001A (en) | Treatment of diseases | |
| AU2001274446A1 (en) | Vip-related peptides for the treatment of skin disorders | |
| AU2001253560A1 (en) | Methods of treatment | |
| AU3582101A (en) | The treatment of functional gastrointestinal disorders | |
| HK1061528A (en) | Novel arylaminopropane analogues and their use for the treatment of glaucoma | |
| AU2001236361A1 (en) | Treatment of asthma with lfm analogues | |
| AU2002242293A1 (en) | Treatment of neurological disease | |
| AUPQ729000A0 (en) | Treatment of damaged connective tissue |